NEON THERAPEUTICS INC's ticker is NTGN and the CUSIP is 64050Y100. A total of 47 filers reported holding NEON THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $11,000 | +266.7% | 4,010 | +41.4% | 0.00% | – |
| Q4 2019 | $3,000 | +50.0% | 2,835 | +166.2% | 0.00% | – |
| Q3 2019 | $2,000 | -88.2% | 1,065 | -70.5% | 0.00% | – |
| Q2 2019 | $17,000 | -39.3% | 3,612 | -15.7% | 0.00% | – |
| Q1 2019 | $28,000 | +211.1% | 4,286 | +157.9% | 0.00% | – |
| Q4 2018 | $9,000 | -40.0% | 1,662 | -5.8% | 0.00% | – |
| Q3 2018 | $15,000 | – | 1,764 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 9,741,636 | $16,756,000 | 9.49% |
| MYDA Advisors LLC | 155,000 | $267,000 | 0.12% |
| Endurant Capital Management LP | 193,052 | $332,000 | 0.12% |
| FNY Investment Advisers, LLC | 210,000 | $361,000 | 0.11% |
| HARVARD MANAGEMENT CO INC | 505,871 | $870,000 | 0.08% |
| Alambic Investment Management, L.P. | 25,800 | $44,000 | 0.03% |
| OXFORD ASSET MANAGEMENT LLP | 209,307 | $360,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 155,619 | $268,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 116,600 | $201,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 14,371 | $25,000 | 0.00% |